Brokerages predict that Proto Labs Inc (NYSE:PRLB) will report earnings of $0.69 per share for the current quarter, according to Zacks. Three analysts have made estimates for Proto Labs’ earnings, with the highest EPS estimate coming in at $0.70 and the lowest estimate coming in at $0.67. Proto Labs posted earnings of $0.51 per share during the same quarter last year, which would suggest a positive year over year growth rate of 35.3%. The firm is expected to announce its next earnings results before the market opens on Thursday, April 26th.
According to Zacks, analysts expect that Proto Labs will report full-year earnings of $2.86 per share for the current fiscal year, with EPS estimates ranging from $2.83 to $2.89. For the next fiscal year, analysts expect that the business will report earnings of $3.33 per share, with EPS estimates ranging from $3.22 to $3.39. Zacks Investment Research’s EPS averages are a mean average based on a survey of research analysts that that provide coverage for Proto Labs.
Proto Labs (NYSE:PRLB) last released its quarterly earnings data on Thursday, February 8th. The industrial products company reported $0.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.48 by $0.05. The firm had revenue of $94.18 million during the quarter, compared to analysts’ expectations of $92.20 million. Proto Labs had a return on equity of 12.22% and a net margin of 15.03%. The business’s revenue for the quarter was up 30.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.41 earnings per share.
Separately, Zacks Investment Research raised Proto Labs from a “hold” rating to a “buy” rating and set a $115.00 price objective for the company in a research report on Thursday, January 4th. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. Proto Labs currently has a consensus rating of “Hold” and a consensus target price of $85.00.
In other Proto Labs news, Director John B. Goodman sold 2,715 shares of the business’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $106.79, for a total value of $289,934.85. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director John B. Goodman sold 1,114 shares of the business’s stock in a transaction dated Wednesday, March 14th. The stock was sold at an average price of $122.71, for a total value of $136,698.94. Following the completion of the sale, the director now directly owns 11,091 shares of the company’s stock, valued at approximately $1,360,976.61. The disclosure for this sale can be found here. In the last three months, insiders have sold 5,720 shares of company stock valued at $627,080. Insiders own 0.64% of the company’s stock.
Several large investors have recently made changes to their positions in PRLB. Russell Investments Group Ltd. lifted its position in shares of Proto Labs by 51.5% in the third quarter. Russell Investments Group Ltd. now owns 25,005 shares of the industrial products company’s stock worth $2,007,000 after buying an additional 8,504 shares during the last quarter. American International Group Inc. lifted its position in shares of Proto Labs by 6.0% in the third quarter. American International Group Inc. now owns 19,639 shares of the industrial products company’s stock worth $1,577,000 after buying an additional 1,117 shares during the last quarter. Legal & General Group Plc lifted its position in shares of Proto Labs by 9.4% in the third quarter. Legal & General Group Plc now owns 51,429 shares of the industrial products company’s stock worth $4,127,000 after buying an additional 4,426 shares during the last quarter. Schwab Charles Investment Management Inc. lifted its position in shares of Proto Labs by 5.5% in the third quarter. Schwab Charles Investment Management Inc. now owns 110,883 shares of the industrial products company’s stock worth $8,904,000 after buying an additional 5,779 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in shares of Proto Labs by 12.3% in the third quarter. Dimensional Fund Advisors LP now owns 438,869 shares of the industrial products company’s stock worth $35,240,000 after buying an additional 48,172 shares during the last quarter. 98.13% of the stock is owned by institutional investors.
PRLB traded down $0.45 during trading on Friday, reaching $125.75. 138,147 shares of the stock traded hands, compared to its average volume of 166,441. The stock has a market cap of $3,404.35, a price-to-earnings ratio of 65.16, a PEG ratio of 2.59 and a beta of 0.96. Proto Labs has a fifty-two week low of $49.65 and a fifty-two week high of $128.22.
COPYRIGHT VIOLATION WARNING: “$0.69 EPS Expected for Proto Labs Inc (PRLB) This Quarter” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another site, it was copied illegally and republished in violation of United States & international copyright law. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/20/0-69-eps-expected-for-proto-labs-inc-prlb-this-quarter.html.
About Proto Labs
Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.
Get a free copy of the Zacks research report on Proto Labs (PRLB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.